<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: treatment option</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Freezing nerves knocks pain out cold</title>
   	 <description>Using a tiny ball of ice, a minimally invasive interventional radiology treatment called cryoneurolysis safely short circuits chronic pain caused by nerve damage, according to data being presented at the Society of Interventional Radiology's 38th Annual Scientific Meeting in New Orleans.</description>
     <link>http://medicalxpress.com/news/2013-04-nerves-pain-cold.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Sun, 14 Apr 2013 10:00:04 EST</pubDate>
	 <guid isPermaLink="false">news285143481</guid>
	 
</item>
<item>
     <title>Study suggests dexmedetomidine before surgery reduced remifentanil-induced hyperalgesia</title>
   	 <description>Surgical patients who demonstrated heightened pain sensitivity, or hyperalgesia, induced by high doses of a synthetic opioid had their symptoms alleviated by co-treatment with dexmedetomidine, according to new research. Study investigators, who presented their results today at the 29th Annual Meeting of the American Academy of Pain Medicine, concluded that dexmedetomidine may be a new and effective treatment option for opioid-induced hyperalgesia (OIH).</description>
     <link>http://medicalxpress.com/news/2013-04-dexmedetomidine-surgery-remifentanil-induced-hyperalgesia.html</link>
	 <category>Medications</category>
	 <pubDate>Fri, 12 Apr 2013 04:39:36 EST</pubDate>
	 <guid isPermaLink="false">news284960342</guid>
	 
</item>
<item>
     <title>Study demonstrates effects of mutant IDH1 and IDH2 inhibitors in primary tumor models</title>
   	 <description>Agios Pharmaceuticals announced today the publication of two articles in the journal Science by Agios scientists and their collaborators demonstrating the effects of the company's small molecule isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) mutant specific inhibitors in primary human tumor models. These data add to a growing body of scientific research demonstrating the significant promise of targeting mutant IDH1 and IDH2 enzymes as novel approaches to treating cancer.</description>
     <link>http://medicalxpress.com/news/2013-04-effects-mutant-idh1-idh2-inhibitors.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 04 Apr 2013 14:00:01 EST</pubDate>
	 <guid isPermaLink="false">news284301154</guid>
	 
</item>
<item>
     <title>Study tracks variation between hospitals in vena cava filter use</title>
   	 <description>The frequency of vena cava filter (VCF) use to prevent migration of blood clots to the lungs in patients with acute venous thromboembolism (VTE) appears to vary widely and be associated with which hospital provides the patient care, according to a study of California hospitals published Online First by JAMA Internal Medicine.</description>
     <link>http://medicalxpress.com/news/2013-03-tracks-variation-hospitals-vena-cava.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 18 Mar 2013 16:00:01 EST</pubDate>
	 <guid isPermaLink="false">news282828891</guid>
	 
</item>
<item>
     <title>Surgery is superior to radiotherapy in men with localized PCa, Swedish study says</title>
   	 <description>Surgery offers better survival benefit for men with localised prostate cancer, according to a large observational study, conducted by a group of researchers in Sweden and the Netherlands.</description>
     <link>http://medicalxpress.com/news/2013-03-surgery-superior-radiotherapy-men-localized.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 15 Mar 2013 03:00:05 EST</pubDate>
	 <guid isPermaLink="false">news282499092</guid>
	 
</item>
<item>
     <title>Breakthrough in battle against leukemia</title>
   	 <description>Scientists at Griffith University's Institute for Glycomics and The Saban Research Institute of Children's Hospital Los Angeles have discovered a critical weakness in leukaemic cells, which may pave the way to new treatments.</description>
     <link>http://medicalxpress.com/news/2013-03-breakthrough-leukemia.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 13 Mar 2013 10:13:54 EST</pubDate>
	 <guid isPermaLink="false">news282388426</guid>
	 
</item>
<item>
     <title>Walking away from back pain</title>
   	 <description>Lower back pain is a common complaint, and treatment often requires many hours of physical therapy over multiple weekly clinic visits—a costly commitment. Now Dr. Michal Katz-Leurer of Tel Aviv University's Stanley Steyer School of Health Professions at the Sackler Faculty of Medicine says that a simple aerobic walking program is as effective in alleviating lower back pain as muscle strengthening programs that require specialized equipment in rehabilitation clinics. The program includes walking two to three times a week for a period of 20 to 40 minutes,</description>
     <link>http://medicalxpress.com/news/2013-03-pain.html</link>
	 <category>Health</category>
	 <pubDate>Tue, 05 Mar 2013 12:16:58 EST</pubDate>
	 <guid isPermaLink="false">news281708211</guid>
	 
</item>
<item>
     <title>FDA approves drug for older women experiencing painful sex</title>
   	 <description>(HealthDay)—The U.S. Food and Drug Administration has approved a new drug to treat postmenopausal women who experience pain during sex, the agency announced Tuesday.</description>
     <link>http://medicalxpress.com/news/2013-02-fda-drug-older-women-experiencing.html</link>
	 <category>Medications</category>
	 <pubDate>Tue, 26 Feb 2013 18:03:55 EST</pubDate>
	 <guid isPermaLink="false">news281124170</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/fdaapprovesd.jpg" width="90" height="90" />
</item>
<item>
     <title>Asthma drug found highly effective in treating chronic, severe hives and itch</title>
   	 <description>An international team of researchers has found that a once-a-month, high-dose injection of a commonly used asthma drug is highly effective in treating teens and adults chronically afflicted with hives and severe, itchy rash. The drug, omalizumab, was tested on 323 people at 55 medical centers for whom standard antihistamine therapy failed to quell their underlying, allergy-like reaction, known as chronic idiopathic urticaria or chronic spontaneous urticaria.</description>
     <link>http://medicalxpress.com/news/2013-02-asthma-drug-highly-effective-chronic.html</link>
	 <category>Immunology</category>
	 <pubDate>Sun, 24 Feb 2013 13:00:29 EST</pubDate>
	 <guid isPermaLink="false">news280917558</guid>
	 
</item>
<item>
     <title>FDA gives nod to botox to treat overactive bladder</title>
   	 <description>(HealthDay)—The U.S. Food and Drug Administration on Friday gave its approval for the use of Botox against a form of urinary incontinence known as overactive bladder.</description>
     <link>http://medicalxpress.com/news/2013-01-fda-botox-overactive-bladder.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Sat, 19 Jan 2013 08:10:01 EST</pubDate>
	 <guid isPermaLink="false">news277800794</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/fdagivesnodt.jpg" width="90" height="90" />
</item>
<item>
     <title>Small peptide ameliorates autoimmune skin blistering disease in mice</title>
   	 <description>Pemphigus vulgaris is a life-threatening autoimmune skin disease that is occurs when the body's immune system generates antibodies that target proteins in the skin known as desomogleins. Desmogleins help to form the adhesive bonds that hold skin cells together and keep the skin intact. Currently, pemphigus vulgaris is treated by long-term immune suppression; however, this can leave the patient susceptible to infection.</description>
     <link>http://medicalxpress.com/news/2013-01-small-peptide-ameliorates-autoimmune-skin.html</link>
	 <category>Immunology</category>
	 <pubDate>Wed, 09 Jan 2013 12:00:06 EST</pubDate>
	 <guid isPermaLink="false">news276953717</guid>
	 
</item>
<item>
     <title>Induction of adult cortical neurogenesis by an antidepressant</title>
   	 <description>The production of new neurons in the adult normal cortex in response to the antidepressant, fluoxetine, is reported in a study published online this week in Neuropsychopharmacology.</description>
     <link>http://medicalxpress.com/news/2013-01-induction-adult-cortical-neurogenesis-antidepressant.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Fri, 04 Jan 2013 09:51:46 EST</pubDate>
	 <guid isPermaLink="false">news276515488</guid>
	 
</item>
<item>
     <title>Gene therapy as a new option for bone defects</title>
   	 <description>(Medical Xpress)—Gene therapy involving modified stem cells obtained from fatty tissue and bone marrow could represent a new option for the treatment of severe orthopaedic injuries to the extremities. This treatment has been developed by Martina Hauser-Schinhan from the University Department of Orthopaedics at the MedUni Vienna during a research fellowship at the Center for Advanced Orthopedic Studies at the Harvard Medical School. The treatment could in future prevent threatened amputations or massive shortenings of bones.</description>
     <link>http://medicalxpress.com/news/2012-12-gene-therapy-option-bone-defects.html</link>
	 <category>Medical research</category>
	 <pubDate>Fri, 07 Dec 2012 13:27:06 EST</pubDate>
	 <guid isPermaLink="false">news274109193</guid>
	 
</item>
<item>
     <title>Endoscopic mucosal resection before radiofrequency ablation is equally effective compared with RFA alone</title>
   	 <description>A new study shows that endoscopic mucosal resection (EMR) before radiofrequency ablation (RFA) is a safe and effective treatment option for patients with nodular Barrett's esophagus (BE) and advanced neoplasia. The performance of EMR before RFA was not associated with a diminished likelihood of success of therapy or an increased rate of stricture compared with those with advanced neoplasia undergoing RFA alone. The study appears in the October issue of GIE: Gastrointestinal Endoscopy, the monthly peer-reviewed scientific journal of the American Society for Gastrointestinal Endoscopy (ASGE).</description>
     <link>http://medicalxpress.com/news/2012-10-endoscopic-mucosal-resection-radiofrequency-ablation.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 16 Oct 2012 13:50:34 EST</pubDate>
	 <guid isPermaLink="false">news269614222</guid>
	 
</item>
<item>
     <title>Denosumab reduces burden of giant-cell tumor of the bone</title>
   	 <description>Treatment with denosumab, a drug targeted against a protein that helps promote bone destruction, decreased the number of tumor giant cells in patients with giant-cell tumor of the bone, and increased new bone formation, according to the results of a phase II study published in Clinical Cancer Research, a journal of the American Association for Cancer Research.</description>
     <link>http://medicalxpress.com/news/2012-09-denosumab-burden-giant-cell-tumor-bone.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 21 Sep 2012 11:41:14 EST</pubDate>
	 <guid isPermaLink="false">news267446466</guid>
	 
</item>
<item>
     <title>Whole-genome scan helps select best treatment for childhood cancer</title>
   	 <description>A whole-genome scan to identify large-scale chromosomal damage can help doctors choose the best treatment option for children with neuroblastoma, one of the most common types of childhood cancer, finds an international collaboration jointly led by The Institute of Cancer Research, London.</description>
     <link>http://medicalxpress.com/news/2012-09-whole-genome-scan-treatment-childhood-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 14 Sep 2012 10:21:24 EST</pubDate>
	 <guid isPermaLink="false">news266836870</guid>
	 
</item>
<item>
     <title>Minimally invasive surgery works well for abdominal aortic aneurysms, Mayo finds</title>
   	 <description> A minimally invasive procedure known as endovascular repair used for abdominal aortic aneurysms has a low rate of complications, even in high-risk patients such as those with kidney, heart or lung problems, a Mayo Clinic study shows. Researchers found that even when aneurysms ruptured, endovascular repair had lower mortality rates than open-abdominal surgery, the other treatment option. The findings are being presented at the Midwestern Vascular Surgical Society Annual Meeting, Sept. 6-8, in Milwaukee, Wis.</description>
     <link>http://medicalxpress.com/news/2012-09-minimally-invasive-surgery-abdominal-aortic.html</link>
	 <category>Cardiology</category>
	 <pubDate>Thu, 06 Sep 2012 00:20:04 EST</pubDate>
	 <guid isPermaLink="false">news266064266</guid>
	 
</item>
<item>
     <title>TAVI improves quality of life in patients with severe aortic stenosis for at least 1 year</title>
   	 <description>Transcatheter aortic valve implantation (TAVI) leads to meaningful improvements in health-related quality of life in patients with severe aortic stenosis that are maintained for at least 1 year, according to a study presented at ESC Congress 2012. The results from the German transcatheter aortic valve interventions registry were presented by Professor Till Neumann, MD, from Essen, Germany.</description>
     <link>http://medicalxpress.com/news/2012-08-tavi-quality-life-patients-severe.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 28 Aug 2012 11:07:08 EST</pubDate>
	 <guid isPermaLink="false">news265370819</guid>
	 
</item>
<item>
     <title>Double attack on SARS</title>
   	 <description>After the SARS-CoV (severe acute respiratory syndrome coronavirus) outbreak in 2003, academia experts in immunology and molecular biology joined forces with industrial vaccine production experts in order to develop preventive and therapeutic measures for SARS.</description>
     <link>http://medicalxpress.com/news/2012-08-sars.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 28 Aug 2012 09:20:58 EST</pubDate>
	 <guid isPermaLink="false">news265364451</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/doubleattack.jpg" width="90" height="90" />
</item>
<item>
     <title>Widely used drug could offer substantial relief to people with chronic cough</title>
   	 <description>New research published Online First in the Lancet is the first to show that gabapentin, a drug widely used to treat pain and seizures, substantially reduces the frequency and severity of coughing and other symptoms associated with the extremely common and difficult-to-treat problem of long-term chronic cough. </description>
     <link>http://medicalxpress.com/news/2012-08-widely-drug-substantial-relief-people.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 27 Aug 2012 18:30:02 EST</pubDate>
	 <guid isPermaLink="false">news265298383</guid>
	 
</item>
<item>
     <title>Mepolizumab almost halves exacerbations in patients with severe asthma</title>
   	 <description>The largest study of patients with severe asthma to date, published in the Lancet special issue on respiratory medicine, shows that those treated with the monoclonal antibody mepolizumab experienced an almost 50 percent reduction in severe exacerbations, emergency room visits, and hospitalizations compared with patients given placebo.</description>
     <link>http://medicalxpress.com/news/2012-08-mepolizumab-halves-exacerbations-patients-severe.html</link>
	 <category>Immunology</category>
	 <pubDate>Thu, 16 Aug 2012 18:30:01 EST</pubDate>
	 <guid isPermaLink="false">news264345938</guid>
	 
</item>
<item>
     <title>The making and unmaking of stem-like, aggressive breast cancer cells</title>
   	 <description>Breast cancers that depend on the hormones estrogen and progesterone are susceptible to treatments targeting these hormones. Take away this dependence and you lose a valuable treatment option. </description>
     <link>http://medicalxpress.com/news/2012-08-unmaking-stem-like-aggressive-breast-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 09 Aug 2012 12:36:20 EST</pubDate>
	 <guid isPermaLink="false">news263734574</guid>
	 
</item>
<item>
     <title>Researchers investigate drug resistant ovarian cancer to improve clinical treatment</title>
   	 <description>(Medical Xpress) -- A new study by TCD researchers investigates drug-resistant ovarian cancer cells. The findings which have been recently published in the international publication, PLoS One will increase understanding of molecular markers in drug-resistant ovarian cancer with a view to improving clinical treatment.</description>
     <link>http://medicalxpress.com/news/2012-08-drug-resistant-ovarian-cancer-clinical.html</link>
	 <category>Cancer</category>
	 <pubDate>Thu, 09 Aug 2012 08:47:52 EST</pubDate>
	 <guid isPermaLink="false">news263720848</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/photo3.jpg" width="90" height="90" />
</item>
<item>
     <title>Off-label drug use common, but patients may not know they're taking them, study finds</title>
   	 <description>Many people have probably heard of off-label drug use, but they may not know when that applies to prescriptions they are taking, a Mayo Clinic analysis found. Off-label drug use occurs when a physician prescribes medication to treat a condition before that use has been approved by the Food and Drug Administration. In a newly published article in Mayo Clinic Proceedings, researchers pose and answer 10 questions about off-label drug use.</description>
     <link>http://medicalxpress.com/news/2012-08-off-label-drug-common-patients-theyre.html</link>
	 <category>Medications</category>
	 <pubDate>Mon, 06 Aug 2012 12:04:10 EST</pubDate>
	 <guid isPermaLink="false">news263473443</guid>
	 
</item>
<item>
     <title>Updated AHA/ACCF guidelines for unstable angina include newest blood-thinning drug</title>
   	 <description>Ticagrelor, a blood-thinning drug approved by the FDA in 2011, should be considered along with older blood thinners clopidogrel and prasugrel for treating patients who are experiencing chest pain or some heart attacks, according to joint updated guidelines issued by the American Heart Association (AHA) Task Force on Practice Guidelines and the American College of Cardiology (ACCF) Foundation.</description>
     <link>http://medicalxpress.com/news/2012-07-ahaaccf-guidelines-unstable-angina-blood-thinning.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 16 Jul 2012 15:03:11 EST</pubDate>
	 <guid isPermaLink="false">news261669774</guid>
	 
</item>
<item>
     <title>The emotion detectives uncover new ways to fight off youth anxiety and depression</title>
   	 <description>Emotional problems in childhood are common. Approximately 8 to 22 percent of children suffer from anxiety, often combined with other conditions such as depression. However, most existing therapies are not designed to treat co-existing psychological problems and are therefore not very successful in helping children with complex emotional issues.</description>
     <link>http://medicalxpress.com/news/2012-07-emotion-uncover-ways-youth-anxiety.html</link>
	 <category>Psychology &amp; Psychiatry</category>
	 <pubDate>Wed, 11 Jul 2012 14:26:46 EST</pubDate>
	 <guid isPermaLink="false">news261235598</guid>
	 
</item>
<item>
     <title>Researchers review muscular dystrophy therapies</title>
   	 <description>Leading muscular dystrophy researcher Dean Burkin, of the University of Nevada School of Medicine summarizes the impact of a new protein therapeutic, MG53, for the treatment of Duchenne muscular dystrophy in an article published this week in Science Translational Medicine.</description>
     <link>http://medicalxpress.com/news/2012-06-muscular-dystrophy-therapies.html</link>
	 <category>Medical research</category>
	 <pubDate>Fri, 22 Jun 2012 09:38:12 EST</pubDate>
	 <guid isPermaLink="false">news259576622</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/7-researchersr.jpg" width="90" height="90" />
</item>
<item>
     <title>Gene clue to drug resistance in African sleeping sickness</title>
   	 <description>(Medical Xpress) -- Researchers have identified a gene that controls susceptibility to drug treatment in Trypanosoma brucei, the parasite responsible for African sleeping sickness.</description>
     <link>http://medicalxpress.com/news/2012-06-gene-clue-drug-resistance-african.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 19 Jun 2012 06:43:54 EST</pubDate>
	 <guid isPermaLink="false">news259306951</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/genecluetodr.jpg" width="90" height="90" />
</item>
<item>
     <title>New weekly fertility injections work as well as daily</title>
   	 <description>New long-lasting weekly injections of fertility hormones are as safe and effective as standard daily injections, according to Cochrane researchers. The researchers compared weekly and daily hormone injections in a Cochrane systematic review and found no difference in pregnancies or serious side effects between the two regimens.</description>
     <link>http://medicalxpress.com/news/2012-06-weekly-fertility-daily.html</link>
	 <category>Obstetrics &amp; gynaecology</category>
	 <pubDate>Tue, 12 Jun 2012 19:00:06 EST</pubDate>
	 <guid isPermaLink="false">news258745420</guid>
	 
</item>
<item>
     <title>Mitochondrial technique is ethical</title>
   	 <description>(Medical Xpress) -- An influential independent body has found that a pioneering mitochondrial transfer technique is ethical. Developed by a team at Newcastle University, the technique aims to prevent the transmission of maternally inherited mitochondrial disorders. </description>
     <link>http://medicalxpress.com/news/2012-06-mitochondrial-technique-ethical.html</link>
	 <category>Genetics</category>
	 <pubDate>Tue, 12 Jun 2012 08:10:27 EST</pubDate>
	 <guid isPermaLink="false">news258707415</guid>
	 
</item>


</channel>
</rss>
